| abstract |
The present invention relates to methods and compositions thereof for the treatment of respiratory diseases, including subsequent viral / bacterial infections, acute / chronic bronchitis, COPD, cystic fibrosis, and inflammatory diseases. Applicants have shown that compounds of Formula 1 and / or 2, or pharmaceutically acceptable inorganic or organic salts thereof, may promote recovery of viability of the cells by restoring sialic sugar binders on the surface of damaged respiratory tract cells. It was identified. |